Send Inquiry

Request To Call Back

Geffon 250 MG Gefitinib Tablets IP

Name: Geffon 250 MG Gefitinib Tablets IP
Brand: Maheshwari Medical Agency
Price: 800 INR
Availability: InStock

Price 800 INR/ Pack

Get a Price/Quote

MOQ : 3 Packs

Geffon 250 MG Gefitinib Tablets IP Specification

Indication
Non-small cell lung cancer (NSCLC)

Pacakaging (Quantity Per Box)
30 tablets

Origin of Medicine
India

Salt Composition
Gefitinib 250 mg

Dosage Form
Tablet

Drug Type
Anticancer

Ingredients
Gefitinib

Physical Form
Tablets

Function
Cancer treatment (EGFR tyrosine kinase inhibitor)

Recommended For
Non-small cell lung cancer (NSCLC) patients

Dosage
As directed by physician

Dosage Guidelines
One tablet daily or as prescribed

Suitable For
Adults

Quantity
30 tablets per box

Storage Instructions
Store below 30°C, protect from moisture

Tablet Shape
Round

Maximum Retail Price (MRP)
As per label, varies by locality

Therapeutic Class
Antineoplastic agent

ATC Code
L01EB01

Route of Administration
Oral

Regulatory Status
Approved in India

Brand Name
Geffon 250 MG

Marketed By
Celon Laboratories Ltd.

Shelf Life
24 months from the date of manufacture

Prescription Required
Yes

Packaging Type
Blister pack

Color
White to off-white

Patient Category
Adults only

Geffon 250 MG Gefitinib Tablets IP Trade Information

Minimum Order Quantity
3 Packs

Supply Ability
100 Packs Per Day

Delivery Time
1 Week

About Geffon 250 MG Gefitinib Tablets IP

We are actively engaged in offering our clients Geffon 250 MG Gefitinib Tablets IP. This medicinal drug is used for the treatment of lung cancer. It works by stopping the growth of cancer cells. The medicine contains Gefitinib that is an enzyme called tyrosine kinase. Due to its efficacy and top-notch formulation, it is widely prescribed by the doctors. Geffon 250 MG Gefitinib Tablets IP comes in preventative packaging that retains the effectiveness of the medicine for the prolonged duration.

Specification

Medicine Type	Allopathic
Manufactured By	Zydus
Usage	Clinical
Brand	Geffon
Packaging Size	3 x 10 Tablets
Packaging Type	Box
Dose	250 mg

Advanced Treatment for NSCLC

Geffon 250 MG Target Tablets are specifically indicated for adults diagnosed with non-small cell lung cancer (NSCLC). By inhibiting the EGFR tyrosine kinase, the tablets help slow down or stop the growth of cancer cells, improving treatment outcomes when prescribed appropriately.

Convenient and Reliable Oral Therapy

The tablets come in easy-to-use blister packs containing 30 doses. Taken once daily by mouth, Geffon 250 MG offers patients a straightforward regimen, making it easier to adhere to ongoing cancer therapy as part of a comprehensive treatment plan.

Strict Quality and Storage Standards

Manufactured in India by Celon Laboratories Ltd., Geffon 250 MG adheres to stringent quality controls. The tablets must be stored below 30C and protected from moisture to maintain their efficacy and safety throughout the labeled 24-month shelf life.

FAQs of Geffon 250 MG Gefitinib Tablets IP:

Q: How should Geffon 250 MG Gefitinib Tablets be taken?

A: Geffon 250 MG tablets should be taken orally, once daily, with or without food, exactly as prescribed by your physician. Do not alter the dosage unless advised by your doctor.

Q: What conditions are Geffon 250 MG Tablets recommended for?

A: These tablets are indicated for adult patients diagnosed with non-small cell lung cancer (NSCLC), particularly when tumors are proven to be sensitive to EGFR tyrosine kinase inhibitors.

Q: When should I take my Geffon 250 MG dose?

A: It is recommended to take Geffon 250 MG Gefitinib Tablets at the same time each day to maintain consistent therapeutic levels, unless your doctor advises otherwise.

Q: Where should Geffon 250 MG Tablets be stored?

A: Store these tablets below 30C in a dry place, protected from moisture, and away from direct sunlight or heat sources to preserve their potency.

Q: What is the process for obtaining Geffon 250 MG in India?

A: Geffon 250 MG is a prescription medication approved in India. It can be obtained from licensed pharmacies upon presenting a valid prescription from a certified healthcare professional.

Q: How does Geffon 250 MG benefit cancer patients?

A: By targeting specific cancer cell receptors (EGFR), Geffon 250 MG helps slow tumor progression in NSCLC, potentially improving response rates and patient quality of life.

Q: Is Geffon 250 MG suitable for all patients?

A: No, Geffon 250 MG is intended for adult patients and should only be used as directed by an oncologist. It is not recommended for children or individuals without a confirmed NSCLC diagnosis.

Tell us about your requirement